methofill 12.5mg/0.25ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 17.5mg/0.35ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 20mg/0.4ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 22.5mg/0.45ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 25mg/0.5ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 27.5mg/0.55ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 30mg/0.6ml solution for injection pre-filled injector
accord-uk ltd - methotrexate - solution for injection - 50mg/1ml
methofill 50 mg/ml solution for injection in pre-filled syringe
accord healthcare limited - methotrexate - solution for injection - 50 milligram(s)/millilitre - other immunosuppressants; methotrexate
hulio solution for injection 40 mg0.8 ml in pre-filled pen
zuellig pharma pte. ltd. - adalimumab - injection, solution - adalimumab 40 mg/0.8ml
methotrexate clonmel 25mg/ml solution for injection in pre-filled syringe
clonmel healthcare ltd - methotrexate - solution for injection in pre-filled syringe - 25 mg/ml - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - active rheumatoid arthritis in adult patients; polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to non-steroidal antiinflammatory drugs (nsaids) has been inadequate; severe forms of psoriasis vulgaris, particularly of the plaque type, which cannot be sufficiently treated with conventional therapy such as phototherapy, puva, and retinoids, and severe psoriatic arthritis